SCI Pharmtech, Inc.
SCI Pharmtech, Inc. (TAI: 4119) is trading at NT$55.50, about ₹167 at today's TWD/INR rate, as of 30 Sep 2026, 1:30 AM ET, up 0.18% today. SCI Pharmtech is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.
Quote
Today's low
NT$54.50
Today's high
NT$55.50
52 week low
NT$39.60
52 week high
NT$73.30
4119 opened at NT$54.50, closed previously at NT$55.40, and has traded between NT$39.60 and NT$73.30 over the past 52 weeks.
About
SCI Pharmtech, Inc., founded in 1987 and based in Taoyuan City, Taiwan, specializes in the comprehensive lifecycle of pharmaceutical components. The company's core operations involve the research and development, manufacturing, and global distribution of active pharmaceutical ingredients (APIs), chemical intermediates, and specialty chemicals. Its extensive portfolio of APIs includes critical compounds such as Articaine HCl, Atomoxetine HCl, Bisoprolol Fumarate, Brinzolamide, Cannabidiol, and Dexmethylphenidate HCl, among many others. Additionally, SCI Pharmtech produces a wide array of intermediate products, featuring substances like Azetidin-3-ol hydrogenchloride, Diethyl Isobutyl Malonate, Pyrogallolaldehyde, and various specialized esters and alcohols, which serve as essential building blocks in chemical synthesis. Beyond its standard product lines, the company also offers custom manufacturing services tailored to specific client needs. SCI Pharmtech maintains a robust international presence, distributing its products to significant markets across the globe, including Italy, China, the United States, Germany, Taiwan, Switzerland, Spain, Japan, and the Netherlands.
Key statistics
Avg. volume
232.62K
Market cap
NT$6.63B
P/E Ratio
108.82
Price-to-sales ratio
5.26
Enterprise value
NT$6.75B
Free cash flow yield
-6.70%
Debt-to-equity ratio
0.20
Return on equity
1.99%
ROIC
2.38%
Beta
0.01
Dividend yield
1.35%
Last dividend
NT$0.75
Financial overview
Revenue
NT$1.34B
Earnings per share
NT$0.90
Free cash flow
-NT$389.68M
Net profit margin
4.77%
Gross margin
22.29%
EBITDA
NT$408.21M
Revenue growth
-11.81%
Similar securities
This is not an investment recommendation
SCI Pharmtech for Indian investors
SCI Pharmtech is listed on the Taiwan Stock Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.
Taxes on SCI Pharmtech for Indian residents
Trading and limits
- Trading hours
- 9:00 am – 1:30 pm SGT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. SCI Pharmtech’s current yield is 1.35%.Dividend tax explained
FAQs
Can I buy SCI Pharmtech on Paasa?
SCI Pharmtech (4119) has been listed on the Taiwan Stock Exchange since 2004, in the Drug Manufacturers - Specialty & Generic industry. SCI Pharmtech is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.
How much does one SCI Pharmtech share cost in rupees?
One SCI Pharmtech share is NT$55.50 — about ₹167 at a TWD/INR rate of 3.02 on 29 Sep 2026. Both the SCI Pharmtech price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for investing abroad from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.
How are gains on SCI Pharmtech shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the TWD/INR rate on the purchase and the sale date, so the rupee move counts alongside the SCI Pharmtech price.
Does SCI Pharmtech pay a dividend, and how is it taxed in India?
Yes. SCI Pharmtech pays a dividend and the current yield is 1.35%; the last declared dividend was NT$0.75 per share, about ₹2.26. Dividends are taxed at your slab rate in India.
When does TAI trade, in Indian time?
The Taiwan Stock Exchange trades 6:30 am – 11:00 am IST in Indian time.
Do I have to declare SCI Pharmtech shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.
Does the rupee rate affect what I make on SCI Pharmtech?
Yes. SCI Pharmtech is priced in TWD, so your rupee outcome combines the TWD move with the TWD/INR move between the day you remit and the day you convert back.